NCT03057002 - UTSW HP [13-C] Pyruvate Injection in HCM | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

May 17, 2023

Study Completion Date

May 17, 2023

Conditions

Cardiomyopathy, HypertrophicDilated CardiomyopathyDuchenne Muscular DystrophyCardiac SarcoidosisBecker Muscular DystrophyHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection Fraction

Interventions

DIAGNOSTIC_TEST

Hyperpolarized 13C-Pyruvate

All subjects will be observed for myocardial hyperpolarized \[1-13C\]pyruvate flux during magnetic resonance spectroscopic imaging.

Trial Locations (1)

75390

UT Southwestern Medical Center - Advanced Imaging Research Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER